International Clinical Trial: A Randomized, Open-Label, Blinded Endpoint Evaluation Study of Early Evolocumab Administration in Patients with Atherosclerotic Acute Ischemic Stroke Following Successful Thrombectomy

Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600117460) titled 'A Randomized, Open-Label, Blinded Endpoint Evaluation Study of Early Evolocumab Administration in Patients with Atherosclerotic Acute Ischemic Stroke Following Successful Thrombectomy' on Jan. 23.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: The Affiliated Hospital of Xuzhou Medical University

Condition: Acute ischemic stroke

Intervention: Intervention group:Thrombectomy Alone + Evolocumab

Thrombectomy Alone: Mechanical thrombectomy was performed in accordance with guidelines (which may include necessary angioplasty/stent placement). Patients who received bridging intravenous th...